Current controversies and challenges in allergic rhinitis management
Author(s)
Price, David
Smith, Pete
Hellings, Peter
Papadopoulos, Nikos
Fokkens, Wytske
Muraro, Antonella
Murray, Ruth
Chisholm, Alison
Demoly, Pascal
Scadding, Glenis
Mullol, Joaquim
Lieberman, Phil
Bachert, Claus
Moesges, Ralph
Ryan, Dermot
Bousquet, Jean
Griffith University Author(s)
Year published
2015
Metadata
Show full item recordAbstract
There are many obstacles in the path of effective allergy management, in general, and allergic rhinitis (AR) control, in particular. Chief among them are: insufficient symptom relief in some patients provided by some currently considered first-line AR treatments in real life; an over-reliance on randomized controlled trials to direct AR guideline recommendations; the need for a broader interpretation of the AR evidence base (to include randomized controlled trials and real-life studies); poorly designed and interpreted studies; and lack of an AR control concept and common language of control. These controversies are fully ...
View more >There are many obstacles in the path of effective allergy management, in general, and allergic rhinitis (AR) control, in particular. Chief among them are: insufficient symptom relief in some patients provided by some currently considered first-line AR treatments in real life; an over-reliance on randomized controlled trials to direct AR guideline recommendations; the need for a broader interpretation of the AR evidence base (to include randomized controlled trials and real-life studies); poorly designed and interpreted studies; and lack of an AR control concept and common language of control. These controversies are fully reviewed here and challenging solutions have been presented.
View less >
View more >There are many obstacles in the path of effective allergy management, in general, and allergic rhinitis (AR) control, in particular. Chief among them are: insufficient symptom relief in some patients provided by some currently considered first-line AR treatments in real life; an over-reliance on randomized controlled trials to direct AR guideline recommendations; the need for a broader interpretation of the AR evidence base (to include randomized controlled trials and real-life studies); poorly designed and interpreted studies; and lack of an AR control concept and common language of control. These controversies are fully reviewed here and challenging solutions have been presented.
View less >
Journal Title
Expert Review of Clinical Immunology
Volume
11
Issue
11
Subject
Immunology
Immunology not elsewhere classified
Allergic rhinitis
Clinical relevance
Randomized controlled trials
Real life
Control
Guidelines